Table: OncoTherapy Science -9-MTH group results
Jan 29 (Reuters)-
OncoTherapy Science Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2015 Dec 31, 2014 Mar 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 210 mln 398 mln
(-47.0 pct) (-47.9 pct)
Operating loss 2.27 loss 1.61
Recurring loss 2.26 loss 1.58
Net loss 2.12 loss 993 mln
EPS loss 14.45 yen loss 6.77 yen
Ann Div NIL NIL
-Q2 div
-Q4 div NIL NIL
NOTE - OncoTherapy Science Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T
((Tokyo Headline News Desk +813 6441 1812))